SciELO - Scientific Electronic Library Online

 
vol.21 número4Efectos de una intervención educativa frente a la actitud de donar órganos en escolares de la columna de TalcahuanoEvaluación del impacto de un programa de formación en Entrevista Motivacional a enfermería nefrológica índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • En proceso de indezaciónCitado por Google
  • No hay articulos similaresSimilares en SciELO
  • En proceso de indezaciónSimilares en Google

Compartir


Enfermería Nefrológica

versión On-line ISSN 2255-3517versión impresa ISSN 2254-2884

Resumen

BONACHE TUR, Débora et al. Results of immunoadsorption in the ABOi kidney transplantation and humoral rejection in a hospital hemodialysis unit. Enferm Nefrol [online]. 2018, vol.21, n.4, pp.386-392. ISSN 2255-3517.  http://dx.doi.org/10.4321/s2254-28842018000400008.

Introduction:

The non-selective immunoadsorption treatment was introduced in our hospital hemodialysis unit with the aim of allowing desensitization prior to a kidney transplant with blood group incompatibility and the treatment of antibody-mediated rejection.

Aim:

To analyze the results of the non-selective immunoadsorption technique in a hospital hemodialysis unit.

Material and methods:

Retrospective descriptive study of the first 18 patients treated in our center with non-selective immunoadsorption (years 2012-2017) in the indications for ABOi transplant conditioning and treatment of humoral rejection.

Results:

During a period of 5 years, 128 non-selective immunoadsorption sessions were analyzed. 38.9% (n= 7) of cases for desensitization prior to renal transplantation with incompatibility of blood group and 61.1% (n=11) remaining for the treatment of antibody-mediated rejection.

In the first case, an average of 8±0.6 sessions of immunoadsorption prior to kidney transplantation were performed and 57.1% were complemented by 2 subsequent sessions. The concomitant treatment was protocolled with rituximab and immunoglobulins, 57.1% requiring plasma exchanges. In the second case, an average of 5.9±2 immunoadsorption sessions were carried out. The concomitant treatment was the same and 27.3% performed plasma exchanges.

Conclusions:

Kidney transplantation from ABOi living donor after desensitization was possible in 100% of patients. 72.7% of patients treated for antibody-mediated rejection currently maintain graft functionality.

Palabras clave : kidney transplantation; blood group incompatibility; immunosorbent technique; desensitization; rituximab.

        · resumen en Español     · texto en Español     · Español ( pdf )